Status:
COMPLETED
Effectiveness of Laying-on-of-hands for Sickle Cell Disease
Lead Sponsor:
MOA Health Science Foundation
Conditions:
Sickle Cell Disease
Pain Crisis Recurrent
Eligibility:
All Genders
3-40 years
Phase:
PHASE2
Brief Summary
The objective of this study is to evaluate the effectiveness of 1-year administration of laying-on-of-hands on the morbidity and mortality of patients with sickle cell disease in Africa.
Detailed Description
Patients with sickle cell disease (SCD) have a high risk of premature death in Africa, mainly due to insufficient medical services. SCD patients often visit emergency department and need hospitalizati...
Eligibility Criteria
Inclusion
- patients with symptoms associated with sickle cell disease
- those able to receive laying-on-of-hands every weekday for 1 year
- those able to receive conventional medical treatment whenever necessary
- those able to receive blood test at the beginning, after 6 month and after 1 year
Exclusion
- those who wish to use other complementary and alternative therapies along with laying-on-of-hands
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01518218
Start Date
March 1 2006
End Date
December 1 2009
Last Update
April 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The national medical center for sickle cell disease
Kinshasa, Democratic Republic of the Congo